LP32685-7Carisoprodol+MeprobamateActive
Description
LP32685-7 Carisoprodol+Meprobamate
Carisoprodol (N-isopropylmeprobamate, Soma, ingredient of Soma Compound) is a carbamate derivative first synthesized in 1959 and used clinically as a muscle relaxant and sedative. Carisoprodol is known to be metabolized to meprobamate and hydroxyl-meprobamate.
Meprobamate is the major metabolite of carisoprodol, and is a CNS depressant in its own right, indicated for the management of anxiety disorders or for short-term treatment of anxiety symptoms. Use of these drugs begins with a prescription for muscular pain or anxiety, and abuse may develop for the sedative-hypnotic effects.
Source: LOINC partner 1
Basic Part Properties
- Name
- Carisoprodol+Meprobamate
- Type
- Component
- Created On
- 2003-10-23
- Construct for LOINC Short Name
- Carisoprodol+Meprob
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP32685-7
Language Variants Get Info
- zh-CNChinese (China)
- 异丙基甲丁双脲+氨甲丙二酯
- nl-NLDutch (Netherlands)
- carisoprodol + meprobamaat
- et-EEEstonian (Estonia)
- Karisoprodool + meprobamaat
- fr-BEFrench (Belgium)
- Carisoprodol+Méprobamate
- fr-CAFrench (Canada)
- Carisoprodol+Méprobamate
- it-ITItalian (Italy)
- Carisoprodol+Meprobamato
- ru-RURussian (Russian Federation)
- Каризопродол+Мепробамат
- es-ESSpanish (Spain)
- Carisoprodol+Meprobamato
Synonyms: Mio Relax (nombre comercial) - tr-TRTurkish (Turkey)
- Karizoprodol+Meprobamat
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright